PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-17.71%
Negative net income growth while VUZI stands at 11.25%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
21.84%
D&A growth well above VUZI's 22.92%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-86.75%
Negative yoy deferred tax while VUZI stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-179.37%
Both reduce yoy usage, with VUZI at -19.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-408.74%
Negative yoy inventory while VUZI is 80.56%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
50.00%
Lower 'other non-cash' growth vs. VUZI's 100.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-67.63%
Both yoy CFO lines are negative, with VUZI at -38.64%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-33.46%
Both yoy lines negative, with VUZI at -18.60%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-68.07%
Negative yoy purchasing while VUZI stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
6.04%
Liquidation growth of 6.04% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
69.76%
Growth well above VUZI's 6.90%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-166.45%
Both yoy lines negative, with VUZI at -13.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
67.32%
Stock issuance far above VUZI's 124.06%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-5.83%
We cut yoy buybacks while VUZI is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.